Fast Track Action Committee on Biosafety and Biosecurity (FTAC)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2015
|
|
FDA Acute Radiation Syndrome (ARS) Action Team
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
NIAID
|
2018
|
|
FDA Cancer Imaging Program (CIP) Bi-annual Meeting
|
Meeting/ Workshop
|
FDA
|
NCI
|
2011
|
|
FDA Collaboration - Psilocybin Research
|
Research Initiative
|
FDA
|
CC
|
2020
|
|
FDA Microbiology Devices Panel of the Medical Devices Advisory Committee
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIAID
|
2017
|
|
FDA Risk Evaluations and Midigation workshop (FDA REMS)
|
Meeting/ Workshop
|
FDA
|
OD/ DPCPSI/ ORWH
|
2020
|
|
FDA Substance Registry System Public Interface
|
Resource Development
|
FDA
|
NLM
|
2009
|
|
FDA Uterine Fibroids Working Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
NICHD, OD/ DPCPSI/ ORWH
|
2017
|
|
FDA-NIH Joint Leadership Council
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NHLBI, NIAID, NIDA, NIDDK, NINDS, OD/ IMOD, OD/ OER, OD/ OSP
|
2010
|
|
FDA/NIMH Points of Contact Working Group Meeting - Drugs
|
Committee, Advisory Group, or Work Group
|
FDA
|
NIMH
|
2020
|
|
Federal Dietary Reference Intakes Steering Committee
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, OASH
|
NHLBI, NIDDK, OD/ DPCPSI, OD/ DPCPSI/ ONR
|
2005
|
|
Federal Experts Security Advisory Panel (FESAP)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2010
|
|
Federal HIV Web Council (FHWC) (HIV.gov)
|
Committee, Advisory Group, or Work Group
|
OASH, CDC, FDA, HRSA, IHS, SAMHSA, ACF
|
NIAID, NIDA, OD/ DPCPSI/ OAR
|
2006
|
|
Federal Hypertension Control Leadership Council
|
Meeting/ Workshop
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, ASPR, ONC
|
NHLBI, NINDS
|
2020
|
|
Federal Interagency Breastfeeding Working Group
|
Committee, Advisory Group, or Work Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
NCI, NHLBI, NICHD, NIDDK
|
2009
|
|
Federal Interagency Workgroup on Improving Diagnostic Safety and Quality in Health Care.
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA, IHS, ONC, SAMHSA
|
NIBIB, NLM, CC, NCATS, NCI
|
2018
|
|
Federal Lead Action Plan Workgroup
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
NICHD
|
|
|
Federal RePORTER
|
Resource Development
|
ACF, ACL, AHRQ, CDC, FDA
|
OD/ OER
|
2008
|
|
Federal Supply and Demand of Isotopes
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI, NIBIB
|
2012
|
|
Federal Tuberculosis (TB) Task Force
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
NIAID, NICHD
|
1991
|
|
Federal Working Group on Bone Diseases
|
Committee, Advisory Group, or Work Group
|
CDC, CMS, FDA
|
CSR, NCATS, NCI, NEI, NIA, NIAID, NIAMS, NICHD, NIDCR, NIDDK, OD/ DPCPSI, OD/ DPCPSI/ ORWH
|
1993
|
|
Federal Working Group on Dietary Supplements (FWGoDS)
|
Meeting/ Workshop
|
AHRQ, CDC, HRSA, IHS, FDA
|
CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM
|
2005
|
|
Filovirus Animal Non-Clinical Group (FANG)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
NIAID
|
2011
|
|
Filovirus Animal Non-Clinical Group (FANG) Workshop
|
Meeting/ Workshop
|
CDC, FDA, OS
|
NIAID
|
2018
|
|
FNIH Advanced Medicines Partnership on Gene Therapy
|
Research Initiative
|
FDA
|
NCATS
|
2019
|
|
|